Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 12, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

9.9K

A network flow-based method to predict anticancer drug sensitivity.

Yufang Qin1, Ming Chen1, Haiyun Wang2

  • 1College of Information Technology, Shanghai Ocean University, Shanghai, China.

Plos One
|May 21, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Premature Aortic Stiffness in Relation to Cerebral Small Vessel Disease, Cognitive Decline, Major Cardiovascular Events and Mortality in Dialysis.

American journal of nephrology·2026
Same author

Reprint of: Effect of perioperative preemptive analgesia on hippocampal GABAA receptor α1/α5 balance in aged mild cognitive impairment rats.

Brain research bulletin·2026
Same author

AdPrST:An Adversarial Graph Deep Learning Pre-clustering Framework for Deciphering Spatiotemporal Structures in Spatially Resolved Transcriptomics.

IEEE transactions on computational biology and bioinformatics·2026
Same author

Experimental synthesis of vector-twisted beams with controllable higher-order Poincaré polarization states.

Optics letters·2026
Same author

Primary epithelioid angiosarcoma of thyroid: A case report and review of literature.

International journal of immunopathology and pharmacology·2026
Same author

Corrigendum to "Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway" [Int. Immunopharmacol. 177 (2026) 116526].

International immunopharmacology·2026
Same journal

Invaders taking over-Mollusc faunal change in volcanic barrier lakes of the Albertine Rift biodiversity hotspot.

PloS one·2026
Same journal

AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways.

PloS one·2026
Same journal

Performance patterns and records in the world aquatics masters championships: Where do the most frequently represented nations among the top-ten masters swimmers come from?

PloS one·2026
Same journal

Modeling diurnal Temperature-Rainfall relationships under multicollinearity using PLS-SEM: A case study of Ghana.

PloS one·2026
Same journal

Organizational culture, social capital, and emergency capacity in primary healthcare institutions: A cross-sectional structural equation modeling study comparing ordinary and older communities.

PloS one·2026
Same journal

Impact of kidney function on the metabolome in the general population.

PloS one·2026
See all related articles

This study introduces a novel network flow method to predict anticancer drug sensitivity by analyzing pathway activity changes due to genetic alterations. The approach shows comparable results to existing models with fewer features, aiding personalized cancer therapy.

Area of Science:

  • Computational biology
  • Genomics
  • Pharmacogenomics

Background:

  • Individualized cancer treatment requires accurate prediction of anticancer drug sensitivity.
  • Genetic alterations (mutations, copy number alterations) impact cancer pathway activity.
  • Existing models for drug sensitivity prediction can be complex and feature-intensive.

Purpose of the Study:

  • To develop a novel network flow-based method for predicting anticancer drug sensitivity.
  • To leverage pathway topology and genetic alterations for improved drug response prediction.
  • To compare the performance of the new method against existing models using real-world data.

Main Methods:

  • A network flow-based computational model was developed.
  • The model utilizes the topological structure of biological pathways.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.8K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K

Related Experiment Videos

Last Updated: Apr 12, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

9.9K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.8K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
  • Genetic alterations' impact on pathway activity and subsequent drug response was quantified.
  • Model parameters were optimized using drug response data from the Cancer Genome Project (CGP).

    • Main Results:

    • The network flow method demonstrated effective prediction of anticancer drug sensitivities.
    • The model achieved prediction accuracy comparable to the elastic net model.
    • The proposed method requires significantly fewer input features than existing models.
    • 10-fold cross-validation on the CGP dataset validated the model's performance.

    Conclusions:

    • The novel network flow-based method offers a promising approach for predicting anticancer drug sensitivity.
    • This method enhances the potential for personalized cancer therapy by improving treatment effectiveness and safety.
    • The model's efficiency in using fewer features suggests a more streamlined approach to drug sensitivity prediction.